Apollo Cancer Centres has partnered with Zydus Lifesciences to introduce Guardant Health's Shield Multi-Cancer Detection ...
Partnership with Guardant Health expands access to multi-cancer screening as precision diagnostics emerges as a new growth area ...
Zydus and Apollo Hospitals collaborate to enhance access to a multi-cancer blood test for early detection in India.
Grail is awaiting an FDA ruling on a cancer screening test, but already more tests are finding their way into medical ...
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced its Shieldâ„¢ blood test for colorectal cancer screening (CRC) is now covered for eligible UnitedHealth Group ...
As of July 1, Ontarians age 45 and up are eligible to receive the at-home fecal immunochemical screening test — or FIT — that ...
Ontario is the second province in Canada to lower the routine colorectal cancer screening age from age 50 to 45.
Ontario is the second province in Canada to lower the routine colorectal cancer screening age from age 50 to 45.
Cases of colorectal cancer are on the rise, surpassing breast and brain cancer as the leading cause of cancer deaths among ...
Earlier this week, Labcorp announced the nationwide availability of ColoSense, the first FDA-approved RNA-based at-home ...
Rates of rectal cancer deaths are rising in adults under 50.
Each unit of cost invested in Helicobacter pylori screening can generate approximately a fivefold return in gastric cancer ...